avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Cebpa | mm10_v2_chr7_+_35119285_35119301 | 0.58 | 2.1e-04 | Click! |
Cebpg | mm10_v2_chr7_-_35056467_35056556 | 0.06 | 7.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_13623967 Show fit | 16.89 |
ENSMUST00000108525.2
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 5 |
|
chr7_+_13733502 Show fit | 13.71 |
ENSMUST00000086148.6
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 |
|
chr7_-_14123042 Show fit | 10.67 |
ENSMUST00000098809.2
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 3 |
|
chr7_-_46742979 Show fit | 6.69 |
ENSMUST00000128088.1
|
serum amyloid A 1 |
|
chr7_-_13989588 Show fit | 6.60 |
ENSMUST00000165167.1
ENSMUST00000108520.2 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 4 |
|
chr2_+_173153048 Show fit | 6.36 |
ENSMUST00000029017.5
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
|
chr7_+_46751832 Show fit | 5.67 |
ENSMUST00000075982.2
|
serum amyloid A 2 |
|
chr3_+_19957088 Show fit | 5.55 |
ENSMUST00000108328.1
|
ceruloplasmin |
|
chr3_+_19957037 Show fit | 5.37 |
ENSMUST00000091309.5
ENSMUST00000108329.1 ENSMUST00000003714.6 |
ceruloplasmin |
|
chr7_-_14254870 Show fit | 5.35 |
ENSMUST00000184731.1
ENSMUST00000076576.6 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 15.8 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 15.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 11.1 | GO:0008202 | steroid metabolic process(GO:0008202) |
1.8 | 10.6 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.1 | 6.7 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
2.1 | 6.4 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.2 | 5.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.4 | 5.1 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 4.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 3.5 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 15.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 13.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 12.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.8 | 10.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.0 | 3.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 3.3 | GO:0005811 | lipid particle(GO:0005811) |
1.1 | 3.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 2.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.6 | 2.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 1.7 | GO:0031526 | brush border membrane(GO:0031526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 39.5 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
1.6 | 15.8 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 13.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 11.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.4 | 10.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 6.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 5.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 5.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 5.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 3.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 15.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 10.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 6.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 6.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 4.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 3.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 2.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 2.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 2.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 15.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 12.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 6.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 6.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 3.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 2.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 2.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.3 | 1.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 1.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |